Ordering Recommendation

Preferred test to follow-up presumptive results. For general screening, Amphetamines Urine Screen with Reflex to Quantitation (2012209) is preferred.

Mnemonic
AMPS UR
Methodology

Quantitative Liquid Chromatography-Tandem Mass Spectrometry

Performed

Sun-Sat

Reported

1-4 days

New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
Collect

Random urine.

Specimen Preparation

Transfer 0.5 mL urine with no additives or preservatives to an ARUP Standard Transport Tube. (Min: 0.3 mL)

Storage/Transport Temperature

Room temperature

Unacceptable Conditions

Specimens exposed to repeated freeze/thaw cycles.

Remarks
Stability

Ambient: 1 week; Refrigerated: 1 month; Frozen: 3 years

Reference Interval

Effective November 11, 2018

Drugs Covered Cutoff Concentrations
Amphetamine 50 ng/mL
Methamphetamine 200 ng/mL
Methylenedioxyamphetamine (MDA) 200 ng/mL
Methylenedioxymethamphetamine (Ecstasy, MDMA) 200 ng/mL
Methylenedioxyethylamphetamine (Eve, MDEA) 200 ng/mL
Phentermine 200 ng/mL

Interpretive Data

Methodology: Quantitative Liquid Chromatography-Tandem Mass Spectrometry.

Positive cutoff:
200 ng/mL unless specified below:
Amphetamine 50 ng/mL

For medical purposes only; not valid for forensic use.

The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory. 

Compliance Statement B: For laboratory developed tests not using a RUO kit, and for FDA approved, cleared or 510(k) exempt assays with alterations. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Note
Hotline History
N/A
CPT Codes

80325; 80359 (Alt code: G0480)

Components
Component Test Code* Component Chart Name LOINC
2010077 Amphetamine, Urn, Quant 19346-6
2010078 Methamphetamine, Urn, Quant 3780-4
2010079 MDA, Urn, Quant 18355-8
2010080 MDMA, Urn, Quant 19570-1
2010081 MDEA, Urn, Quant 27085-0
2010082 Phentermine, Urn, Quant 20557-5
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Adderall
  • Amphetamine
  • Benzedrine
  • Carbex
  • Deprenyl
  • Desoxyephedrine
  • Desoxyn
  • Dexedrine
  • Dextroamphetamine
  • Ecstasy
  • Eldepryl
  • Emsam
  • Eve
  • Lisdexamfetamine
  • MDA
  • MDEA
  • MDMA
  • MDMA Confirmation, Urine
  • Methamphetamine
  • Methedrine
  • Pain Management
  • Pain Management, Amphetamines, Quantitative, with medMATCH, Urine
  • Pain Management, Amphetamines, with Confirmation with medMATCH, Urine
  • Pain Management, MDMA/MDA Quantitative, Urine
  • Pain Management, MDMA/MDA, Quantitative, with medMATCH, Urine
  • Paremyd
  • Selegiline
  • Vicks Inhaler
  • Vyvanse
  • XTC
  • Zelapor
Amphetamines, Urine, Quantitative